| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), DCOY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 34.8K | - | - | |
| CFO | 11.4K | - | - | |
| Other | 4.2K | - | - | |
| Other | 3.9K | - | - | |
| Dir | 3.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Hanish Arnold C46 | Director | Sell | 27 | $0.64 | $17.27 | -100% | -13.1% | - | |
| Nov 20, 2025 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 20,000 | $0.80 | $16,000.00 | +11,299% | +1.3% | - | |
| Nov 20, 2025 | Hanish Arnold C46 | Director | Buy | 5,000 | $0.75 | $3,740.50 | +33,333% | +1.3% | - | |
| Jun 7, 2022 | Burleson Tess | - | Buy | 27,700 | $0.18 | $4,986.00 | +636.8% | +7.0% | -62.5% | |
| Jun 7, 2022 | Lieber Jonathan I | - | Buy | 37,500 | $0.19 | $7,016.25 | New | +7.0% | -62.5% | |
| Jun 6, 2022 | McVicar William K. | - | Buy | 26,553 | $0.19 | $4,999.93 | New | +5.1% | -64.0% | |
| Jun 3, 2022 | Hanish Arnold C46 | - | Buy | 28,000 | $0.18 | $5,152.00 | +152.6% | +17.0% | -65.2% | |
| May 31, 2022 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 28,000 | $0.18 | $5,040.00 | +23.3% | +19.4% | -68.7% | |
| May 26, 2022 | Arthur David J. | Chief Executive Officer | Buy | 43,900 | $0.18 | $7,984.60 | +16.9% | +15.7% | -66.9% | |
| Mar 3, 2022 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 76,246 | $0.39 | $29,812.19 | +223.8% | -54.7% | -77.8% |